316 related articles for article (PubMed ID: 21773649)
1. [Parvovirus B19 among blood donors from three hospitals in Santiago, Chile].
Lévican J; Torres M; Gaggero N; Corvalán R; Gaggero A
Rev Med Chil; 2011 Feb; 139(2):143-9. PubMed ID: 21773649
[TBL] [Abstract][Full Text] [Related]
2. Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR).
Knöll A; Louwen F; Kochanowski B; Plentz A; Stüssel J; Beckenlehner K; Jilg W; Modrow S
J Med Virol; 2002 Jun; 67(2):259-66. PubMed ID: 11992588
[TBL] [Abstract][Full Text] [Related]
3. Detection of human parvovirus B19 in cancer patients using ELISA and real-time PCR.
Zaki SA
Indian J Med Microbiol; 2012; 30(4):407-10. PubMed ID: 23183464
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of human parvovirus B19 DNA and antibodies in blood donors from four Chinese blood centers.
Ke L; He M; Li C; Liu Y; Gao L; Yao F; Li J; Bi X; Lv Y; Wang J; Hirsch ML; Li W
Transfusion; 2011 Sep; 51(9):1909-18. PubMed ID: 21382040
[TBL] [Abstract][Full Text] [Related]
5. Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection.
Hsu TC; Chen TY; Lin MC; Tzang BS; Tsay GJ
J Gastroenterol Hepatol; 2005 May; 20(5):733-8. PubMed ID: 15853987
[TBL] [Abstract][Full Text] [Related]
6. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood.
Lehmann HW; Knöll A; Küster RM; Modrow S
Arthritis Rheum; 2003 Jun; 48(6):1631-8. PubMed ID: 12794831
[TBL] [Abstract][Full Text] [Related]
7. Evidence for persistence of human parvovirus B19 DNA in bone marrow.
Cassinotti P; Burtonboy G; Fopp M; Siegl G
J Med Virol; 1997 Nov; 53(3):229-32. PubMed ID: 9365887
[TBL] [Abstract][Full Text] [Related]
8. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients.
Lundqvist A; Isa A; Tolfvenstam T; Kvist G; Broliden K
J Clin Virol; 2005 May; 33(1):71-4. PubMed ID: 15797368
[TBL] [Abstract][Full Text] [Related]
9. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
Beersma MF; Claas EC; Sopaheluakan T; Kroes AC
J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors.
Oh DJ; Lee YL; Kang JW; Kwon SY; Cho NS
Korean J Lab Med; 2010 Feb; 30(1):58-64. PubMed ID: 20197724
[TBL] [Abstract][Full Text] [Related]
11. Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin.
Cassinotti P; Siegl G; Michel BA; Brühlmann P
J Med Virol; 1998 Nov; 56(3):199-204. PubMed ID: 9783685
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Roche LightCycler parvovirus B19 quantification kit for the diagnosis of parvovirus B19 infections.
Braham S; Gandhi J; Beard S; Cohen B
J Clin Virol; 2004 Sep; 31(1):5-10. PubMed ID: 15288606
[TBL] [Abstract][Full Text] [Related]
13. [Seroprevalence of IgG antibodies against parvovirus B19 among blood donors from Santiago, Chile].
Gaggero A; Rivera J; Calquín E; Larrañaga CE; León O; Díaz P; Gaggero N
Rev Med Chil; 2007 Apr; 135(4):443-8. PubMed ID: 17554452
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence, molecular epidemiology and quantitation of parvovirus B19 DNA levels in Iranian blood donors.
Zadsar M; Aghakhani A; Banifazl M; Kazemimanesh M; Tabatabaei Yazdi SM; Mamishi S; Bavand A; Sadat Larijani M; Ramezani A
J Med Virol; 2018 Aug; 90(8):1318-1322. PubMed ID: 29663448
[TBL] [Abstract][Full Text] [Related]
15. [Parvovirus B19 DNA testing in Polish blood donors, 2004-2010].
Grabarczyk P; Korzeniowska J; Liszewski G; Kalińska A; Sulkowska E; Krug-Janiak M; Kopacz A; Łetowska M; Brojer E
Przegl Epidemiol; 2012; 66(1):7-12. PubMed ID: 22708291
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay.
Kleinman SH; Glynn SA; Lee TH; Tobler L; Montalvo L; Todd D; Kiss JE; Shyamala V; Busch MP;
Transfusion; 2007 Oct; 47(10):1756-64. PubMed ID: 17880600
[TBL] [Abstract][Full Text] [Related]
17. [Research on Parvovirus B19 infections and chronic articular manifestations in a Tunisian hospital].
Regaya F; Khelifa R; Zouari R; Kchir M; Karoui M; Essid R
Arch Inst Pasteur Tunis; 2003; 80(1-4):9-15. PubMed ID: 15941063
[TBL] [Abstract][Full Text] [Related]
18. Human parvovirus B19: prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients.
Jordan J; Tiangco B; Kiss J; Koch W
Vox Sang; 1998; 75(2):97-102. PubMed ID: 9784661
[TBL] [Abstract][Full Text] [Related]
19. [Prevalence of anti-human parvovirus B19 IgG antibody among blood donors in Jilin province].
Wei Q; Li Y; Wang JW; Wang H; Qu JG; Hung T
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):60-2. PubMed ID: 16816866
[TBL] [Abstract][Full Text] [Related]
20. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3.
Liefeldt L; Plentz A; Klempa B; Kershaw O; Endres AS; Raab U; Neumayer HH; Meisel H; Modrow S
J Med Virol; 2005 Jan; 75(1):161-9. PubMed ID: 15543575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
